Non-invasive Testing
|
Transthoracic Doppler, contrast echocardiography |
Easy to perform
Minimal risk
No radiation
Relatively inexpensive
|
|
Cardiac PET |
The most validated non-invasive tool to diagnose CMD
Carries a prognostication value
Accurate perfusion quantification
Less likely to be affected by renal function
Adding CT can allow anatomic assessment of the coronary arteries
Not haematocrit-dependent
Standard post-processing
|
|
CMR |
Validated against invasive measurements and cardiac PET
Myocardial perfusion semi-quantification
No radiation exposure
Excellent spatial and temporal resolution
Allows tissue characterisation with the same study
|
Expensive
Limited prognostication data
Complex post processing
Not widely available
Requires frequent breath holds and longer exam duration
Haematocrit-dependent
Limited in patients with MRI non-compatible devices
Limited in renal failure
|
Cardiac CT |
|
High radiation exposure
Higher risk for contrast-induced nephropathy
Limited in renal failure
Post-processing is complex
Haematocrit-dependent
Limited validation in patients with MVA
Iodinated contrast can cause coronary vasodilation and overestimate myocardial perfusion
|
Invasive Testing
|
Coronary function test |
Confirmatory test to diagnose CMD
Accurately identifies different pathways contributing to MVA including CFR, CBF and coronary artery diameter change
Provides assessment of other haemodynamic measures such as LVEDP and assesses degree of coronary artery stenosis
Carries a prognostication value
Standardised protocol
|
|